Angiogenesis inhibitor TNP-470: cytotoxic effects on human neoplastic cell lines.

Abstract

Angiostatic substance TNP-470 displayed moderate cytotoxicity towards human leukemia HL-60, HL-60/ADR, HL-60/VCR and myeloma ARH77 cell lines with IC50 in the range 5-10 microM of concentrations and slightly higher IC50 for myeloma cell line U266. IC50 for ovarian CH-1, A2780 and A2780/ADR cell lines was in the range 10-15 microM with the exception of platinum-resistant SKOV3 cell line (more than 40 microM ). The IC50 values for MDA-MB-231 and MCF-7 breast carcinoma cell lines were 15 and 25 microM, respectively. In human hemopoietic neoplastic cell lines examined, TNP-470 induced the appearance of subpopulation with sub-G0 DNA content, suggesting the apoptosis-inducing potential of TNP-470 in these cells. No TNP-470-induced drug uptake modulation in drug-resistant leukemia cell line HL-60/VCR was observed. TNP-470 induced accumulation of cells in G0/G1 phase of cell cycle. There was no TNP-470-induced inhibition of MMP collagenase activity or MMP (MMP2 and MMP9) production in the human fibrosarcoma cells HT 1080 in vitro.

Statistics

0200400'03'05'07'09'11'13'15'17
Citations per Year

145 Citations

Semantic Scholar estimates that this publication has 145 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Sedlakova1999AngiogenesisIT, title={Angiogenesis inhibitor TNP-470: cytotoxic effects on human neoplastic cell lines.}, author={Olga Sedlakova and Jan Sedl{\'a}k and Luba Hunakova and Jana Jakubikova and Jozef Duraj and M Sul{\'i}kov{\'a} and Jana Chovancov{\'a} and Branko Chorvath}, journal={Neoplasma}, year={1999}, volume={46 5}, pages={283-9} }